NFE2L2 and lung carcinoma: At the same time, some studies have revealed that nestin can inhibit the ubiquitination proteasome degradation of Nrf2 by Keap1 through competitive binding to Keap1 and promote the oxidative stress ability and chemotherapy resistance of lung cancer.